4 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
#AntiPlatelet #Inhibitors ... #Pharmacology # ... Table #Overview ... #Interactions #Pharmacology ... #Cardiology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... DOACs thereby leading ... metabolization leading ... Chemotherapy #Oncology #Hematology ... Table #Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug Interactions ... With OTC Supplements ... #OTC #supplementals ... #herbal #pharmacology ... #DDI #table #cardiology
Hydroxychloroquine - Risks and Benefits in Lupus
Benefits:
↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
- Prolonged QTc ... other medications leading ... very rare if no interaction ... Benefits #Lupus #pharmacology ... #sideeffects #rheumatology